MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from private
placement, net of offering...
$15,359K
Proceeds from
at-the-market offering, net of...
$13,841K
Common stock issued for
options exercised
$2,767K
Common stock issued for
warrants exercised
$517K
Proceeds from employee
stock purchase plan
$151K
Net cash and cash
equivalents provided by...
$11,557K
Canceled cashflow
$21,078K
Net (decrease)
increase in cash and cash...
-$16,104K
Canceled cashflow
$11,557K
Accounts payable
$19,638K
Change in fair value of
liability classified...
-$12,206K
Amortization of debt issuance
costs and debt...
$8,380K
Depreciation and
amortization
$6,944K
Share-based compensation
$4,551K
Write-off of assets from
clinical trials segment
$2,398K
Prepaid expenses
-$2,033K
Change in fair value of
liability classified...
$247K
Proceeds from asset
disposition
$126K
Principal payments on
long-term debt
$20,000K
Payments made for
financing of insurance...
$991K
Payment of deferred
consideration liability for...
$50K
Principal payments on
financing leases
$37K
Net cash and cash
equivalents used in...
-$24,587K
Canceled cashflow
$56,397K
Net cash and cash
equivalents provided by...
-$3,074K
Canceled cashflow
$126K
Net loss
-$60,606K
Accounts receivable
$12,308K
Inventories
$6,836K
Change in operating
leases
-$452K
Accrued expenses and
other current...
-$448K
Other receivables
$274K
Deferred taxes
-$32K
Other assets
$17K
Other non-current
liabilities
-$11K
Purchases of property and
equipment
$3,200K
Back
Back
Cash Flow
source: myfinsight.com
Oncology Institute, Inc. (TOI)
Oncology Institute, Inc. (TOI)